Related Experiment Video
Updated: Jun 24, 2025
07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
6.5K
COX2-dependent suppression of anticancer immunity
María Cecilia Lira1, Lorenzo Galluzzi2, Claire Vanpouille-Box3
1Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
Trends in Cancer
|May 31, 2024
Summary
Prostaglandin E2 (PGE2) hinders anti-cancer immunity by reducing interleukin-2 (IL2) receptors on T cells. This impairs T cell mitochondrial metabolism, suppressing anti-tumor immune responses.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Prostaglandin E2 (PGE2) is a key mediator in tumor progression.
- PGE2 promotes cancer cell proliferation and suppresses anti-tumor immunity.
- The precise mechanisms of PGE2-mediated immune suppression are under investigation.
Purpose of the Study:
- To elucidate the mechanisms by which PGE2 suppresses T cell-mediated anti-tumor immunity.
- To investigate the role of PGE2 in regulating interleukin-2 (IL2) receptor expression on T cells.
- To determine the impact of PGE2 on T cell mitochondrial metabolism.
Main Methods:
- Analysis of T cells from tumor microenvironments.
- Assessment of interleukin-2 (IL2) receptor expression.
- Measurement of T cell mitochondrial respiration and metabolic activity.
Main Results:
- Prostaglandin E2 (PGE2) downregulates interleukin-2 (IL2) receptors on T cells.
- This downregulation leads to impaired T cell mitochondrial metabolism.
- Reduced T cell function compromises anti-tumor immune responses.
Conclusions:
- PGE2 suppresses anti-cancer immunity by inhibiting T cell function.
- Targeting PGE2 signaling may restore T cell-mediated anti-tumor immunity.
- Interleukin-2 (IL2) receptor signaling and T cell metabolism are critical targets for cancer immunotherapy.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
01:27Cytotoxic T Cells-mediated Immune Response
891
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
891
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:12Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K